CSL Hong Kong Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1000IU complex, Powder for injection (50 IU/mL FVIII)

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Download Laporan Penilaian Awam (PAR)
01-12-2017

Bahan aktif:

Von willebrand factor, Quantity: 1000 IU; Factor VIII, Quantity: 500 IU

Boleh didapati daripada:

CSL Behring Australia Pty Ltd

INN (Nama Antarabangsa):

Factor VIII,Von willebrand factor

Borang farmaseutikal:

Injection, solution

Komposisi:

Excipient Ingredients: water for injections

Laluan pentadbiran:

Intravenous

Tanda-tanda terapeutik:

Aleviate is indicated for: ? the treatment of bleeding episodes including surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the treatment and prophylaxis of bleeding associated with factor FVIII deficiency due to haemophilia A.

Ringkasan produk:

Visual Identification: Clear, colourless solution; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status kebenaran:

Listed (Export Only)

Tarikh kebenaran:

2004-06-17